Exploring the Therapeutic Potential of Fluorinated CXCR4 Inhibitor A1: Insights from Breast Cancer In Vitro Investigations
کلید واژگان
Breast cancerCXCR4
Fluorine
Small molecule
ناشر
Tehran, medical University Tehranسازمان پدید آورنده
Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, IranDepartment of Immunology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
Department of Chemistry, Faculty of Science, Vali-e-Asr University of Rafsanjan, Rafsanjan, Iran
Department of Immunology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran AND Breast Health and Cancer Research Center, Iran University of Medical Science, Tehran, Iran AND Immunology Research Center, Iran University of Medical Sciences, Tehran, Iran
شاپا
1735-15021735-5249
